Grace A. McCarthy

The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Adenocarcinoma

Hannah D. Holly, R. Sears, C. Yeo, 2022, Molecular and cellular biology.

Effect of Hypercapnia, an Element of Obstructive Respiratory Disorders, on Pancreatic Cancer Chemoresistance and Progression.

C. Yeo, D. Nauheim, T. Yeo, 2020, Journal of the American College of Surgeons.

Psychosocial distress is dynamic across the spectrum of cancer care and requires longitudinal screening for patient-centered care

B. Sheppard, T. Sutton, Marina Affi Koprowski, 2022, Supportive Care in Cancer.

The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria

E. Petricoin, Y. Pommier, P. Singh, 2021, Molecular Cancer Therapeutics.

Poly (ADP) ribose glycohydrolase can be effectively targeted in pancreatic cancer.

C. Yeo, M. Pishvaian, K. Olive, 2019, Cancer research.

Deletion of the mRNA stability factor ELAVL1 (HuR) in pancreatic cancer cells disrupts the tumor microenvironment integrity

R. Sears, Aditi Jain, T. Morgan, 2023, NAR cancer.

A Novel 3DNA® Nanocarrier effectively delivers payloads to pancreatic tumors.

C. Yeo, Jessica Bowers, R. Getts, 2023, Translational oncology.

Combined Targeting of PARG and Wee1 Causes Decreased Cell Survival and DNA Damage in an S-Phase–Dependent Manner

C. Yeo, Aditi Jain, K. Bussard, 2020, Molecular Cancer Research.